IPHA vs IMDX
Comparison between Innate Pharma (IPHA, Company) and Insight Molecular Diagnostics Inc (IMDX, Company).
Both IPHA and IMDX are from the Healthcare sector.
5-Year PerformanceIPHA has outperformed IMDX, delivering a return of -11.8% compared to -44.8%
IPHA vs IMDX - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
IPHA vs IMDX - Historical Returns
Returns include dividend reinvestment.
IPHA vs IMDX - Annual Returns (2016 - 2026)
Returns include dividend reinvestment.
| Year | IPHA | IMDX |
|---|---|---|
| 2026 | -2.75% | -30.17% |
| 2025 | -6.42% | +221.89% |
| 2024 | -32.35% | -27.88% |
| 2023 | -17.65% | -63.77% |
| 2022 | -22.29% | -85.74% |
| 2021 | +5.80% | -9.21% |
| 2020 | -43.97% | +7.17% |
| 2019 | +6.45% | +53.06% |
| 2018 | N/A | -70.00% |
| 2017 | N/A | -31.11% |
| 2016 | N/A | -21.67% |
IPHA vs IMDX Drawdown Comparison
The maximum drawdown for IPHA was -85.73%, occurring on Mar 20, 2026. This drawdown has not yet recovered.
The maximum drawdown for IMDX was -99.03%, occurring on Jan 22, 2025. This drawdown has not yet recovered.
The current IPHA drawdown is -78.41%. The current IMDX drawdown is -97.53%.
| Rank | IPHA | IMDX |
|---|---|---|
| #1 | -85.73% May 11, 2020 - Mar 20, 2026 | -99.03% Jan 5, 2016 - Jan 22, 2025 |
| #2 | -52.20% Feb 19, 2020 - May 11, 2020 | N/A |
| #3 | -12.06% Nov 11, 2019 - Jan 2, 2020 | N/A |
| #4 | -10.16% Jan 23, 2020 - Feb 13, 2020 | N/A |
| #5 | -9.99% Jan 8, 2020 - Jan 23, 2020 | N/A |
| #6 | -8.86% Oct 21, 2019 - Nov 5, 2019 | N/A |
| #7 | -4.27% Feb 13, 2020 - Feb 18, 2020 | N/A |
| #8 | -3.22% Nov 7, 2019 - Nov 11, 2019 | N/A |
| #9 | -1.78% Jan 2, 2020 - Jan 6, 2020 | N/A |
Correlation
Correlation between IPHA and IMDX is 0.59 which considered as a moderate positive correlation - the stocks show some tendency to move together.
Select Stocks to Compare
More Comparisons
Compare with similar stocks